A Phase I/IIa Study of AL8326 Combined With Toripalimab in the Treatment of Advanced Solid Tumors.
Clinical trial NCT07392736 · RECRUITING
Trial details
- NCT number
- NCT07392736
- Sponsor
- Advenchen Laboratories, LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-26
- Primary completion
- 2029-11-07
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.